Telehealth Anxiety Prescribing: What Prescribers Can Do

You’re a psychiatrist or PMHNP who treats anxiety disorders. You’ve watched telehealth explode over the past few years, and you’re wondering: Can I really manage my anxiety patients entirely online? What about prescribing benzodiazepines or starting SSRIs over video? Are the rules different for nurse practitioners versus physicians?

The short answer: Yes, you can prescribe anxiety medications via telehealth — but the details depend on your credential (MD/DO vs PMHNP), your state’s laws, and federal controlled substance rules that are still evolving.

Here’s what actually matters for your practice in 2026.

What Psychiatrists Can Do: Full Authority, Minimal Restrictions

If you’re a psychiatrist (MD or DO), you have unrestricted prescribing authority for anxiety disorders in all 50 states. That includes:

• First-line medications: SSRIs (sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), buspirone
• Controlled substances: Benzodiazepines like alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan) — all Schedule IV
• Off-label options: Beta-blockers (propranolol), hydroxyzine, even gabapentin for anxiety

The big question has always been: Can you prescribe controlled substances via telehealth without seeing the patient in person first?

Federal Rules: Extended Flexibility Through 2026

Here’s where we stand as of February 2026:

The DEA’s COVID-era telemedicine flexibilities remain in effect through December 2026. This means you can evaluate a new patient via video and prescribe controlled anxiety medications — including benzodiazepines — without any prior in-person visit.

These temporary rules were extended specifically to prevent a ‘telemedicine cliff’ where millions of patients would suddenly lose access to care. In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these flexibilities.

What’s coming: The DEA is working on permanent telemedicine prescribing regulations expected in late 2026. They’ll likely introduce a special telemedicine registration or some guard rails, but the goal is to preserve remote access while preventing abuse. For now, you can practice as you have been.

Bottom line for psychiatrists: You can do initial anxiety evaluations online, start medications (including benzos when appropriate), and manage ongoing treatment entirely via telehealth. Just follow standard of care — document your clinical rationale, check your state’s prescription drug monitoring program (PDMP), and ensure you’re licensed in the state where your patient is located.

State-Specific Telehealth Rules You Should Know

Most states align with federal policy, but a few have additional considerations:

Florida: Explicitly permits telehealth prescribing of Schedule II controlled substances for psychiatric disorders (though anxiety meds are mostly Schedule IV, so no issue there). You must check Florida’s PDMP (E-FORCSE) before prescribing any controlled substance. If you’re not fully licensed in Florida but have their telehealth provider registration, you cannot prescribe controlled substances remotely.

Texas: Requires a valid patient-provider relationship established via live audio-visual exam. Texas prohibits telemedicine treatment of chronic pain with controlled drugs, but anxiety treatment doesn’t fall under that restriction. You can prescribe benzodiazepines via telehealth if clinically indicated. Must check Texas PMP before prescribing.

California: No special telehealth restrictions on controlled substance prescribing. Standard requirement: appropriate evaluation (which can be done virtually) before prescribing. California has telehealth payment parity laws, so insurers pay the same for virtual visits.

New York: No telehealth-specific prescribing limits. You must check the state PDMP (iSTOP) before every controlled substance prescription — one of the strictest PDMP mandates in the country. Medicare patients may face periodic in-person visit requirements (delayed enforcement through 2024-2025), so verify current policy.

Pennsylvania & Illinois: No telehealth-specific prohibitions for psychiatric prescribing. Follow federal rules and standard of care. Both require PDMP checks.

The practical reality: If you’re a fully licensed psychiatrist treating patients in any of these states via telehealth, you can manage anxiety disorders the same way you would in-person — including prescribing controlled medications when appropriate.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNPs: It’s Complicated (And State-Dependent)

If you’re a Psychiatric Mental Health Nurse Practitioner, your authority to prescribe anxiety medications varies significantly by state. About half of U.S. states grant Full Practice Authority (FPA), meaning you can evaluate, diagnose, and prescribe independently. The other half require physician collaboration or supervision.

Full Practice States: You’re on Equal Footing

In FPA states, your prescribing authority for anxiety meds is essentially equivalent to a psychiatrist’s. You can independently prescribe SSRIs, SNRIs, benzodiazepines, and other anxiolytics in line with your training.

New York (since 2022): Full practice authority for all NPs. No written agreement or collaborative relationship required. You can open your own practice managing anxiety and other mental health conditions completely independently.

Arizona, Washington, Oregon, Alaska, Hawaii, etc.: Full practice authority. You need a DEA registration to prescribe controlled substances, but no physician oversight required.

California (transitioning as of 2023-2026): California introduced the ‘103 NP’ and ‘104 NP’ categories. As of 2023, experienced NPs can practice without standardized physician procedures in certain group settings (103 NP). Starting in 2026, qualified NPs can achieve full independent practice status (104 NP) after maintaining 3 years of good practice. This is a dramatic shift from California’s historically restrictive approach.

Reduced/Restricted Practice States: You Need a Physician Partner

In these states, you need a collaborative agreement with a physician to prescribe medications.

Texas: Highly restricted. You must have a Prescriptive Authority Agreement with a Texas physician. Additionally, Texas limits NP prescribing of Schedule II controlled substances to hospital settings or hospice/terminal care. For anxiety treatment, this means:

• You can prescribe benzodiazepines (Schedule IV) if your delegating physician has authorized it
• You cannot prescribe Schedule II stimulants in outpatient settings (relevant if treating comorbid ADHD)
• The physician must be available for consultation and review charts periodically
• No pathway to independence — Texas hasn’t passed NP FPA legislation

Florida: Requires a written protocol with a physician for all psychiatric NP practice. Florida has a special exemption: psychiatric NPs prescribing psychiatric medications for mental disorders are not subject to the 7-day limit on controlled substance prescriptions that applies to other NPs. So you can prescribe more than 7 days of alprazolam for an anxiety disorder, but you still need that supervising physician protocol on file.

Pennsylvania: Requires collaborative agreement with a physician. The physician must review a percentage of your charts (up to 100% for new patients, typically 100% for Schedule II prescriptions). If your collaborating psychiatrist isn’t comfortable with you prescribing benzodiazepines independently, you might not be able to do so under your agreement. No independent practice pathway yet (bills have been proposed but not passed).

Illinois: Started as a reduced practice state but created a pathway to FPA. After completing 4,000 clinical hours + 250 CE hours post-graduation, you can apply for Full Practice Authority. Even with FPA, you need a one-time physician attestation to prescribe benzodiazepines or Schedule II narcotics — essentially a physician formally acknowledging you’ll be prescribing those classes. After that sign-off, you can prescribe them independently.

The Practical Impact on Telehealth

For telehealth anxiety treatment, these restrictions create real challenges:

In restricted states, you need to find a psychiatrist or physician willing to collaborate — which can cost money (some charge collaboration fees) and may have geographic requirements. For example, in Texas, the physician and NP typically must be within 75 miles of each other.

This affects your ability to practice purely remotely. If you want to join a telehealth platform and treat patients across multiple states, you’re limited to:

1. States where you have full practice authority, OR
2. States where the platform can pair you with a collaborating physician who meets that state’s requirements

Psychiatrists don’t face this issue — they can get licensed in any state (often through the Interstate Medical Licensure Compact) and start treating patients via telehealth immediately.

Reimbursement: What You’ll Actually Get Paid

Understanding reimbursement matters because it affects whether telehealth anxiety treatment is financially viable for your practice.

Medicare Rates (2026)

Medicare pays well for psychiatric medication management:

• Initial psychiatric evaluation (CPT 90792): ~$202
• 15-minute medication follow-up (CPT 99213): ~$95
• 25-minute follow-up (CPT 99214): ~$136
• Therapy add-on (CPT 90833, 30 min): ~$81 additional

Telehealth parity: Medicare pays the same rate for telehealth visits as in-person through at least 2024 (extended into 2025-2026). There was a proposed requirement for periodic in-person visits for tele-mental health, but enforcement has been delayed.

One catch for PMHNPs: Medicare reimburses NPs at 85% of the physician fee schedule when billing under your own NPI. So that $95 follow-up becomes ~$81 for an NP. Some practices use ‘incident to’ billing to get 100% rates, but this is difficult in psychiatry and generally not feasible for telehealth.

Medicaid & Private Insurance

Medicaid: Pays significantly less — often 50-60% of Medicare rates. For example:

• Initial psych eval: ~$85 (vs $202 Medicare)
• 15-min med check: ~$43 (vs $95 Medicare)

High volume can offset the lower rates, but many psychiatrists limit Medicaid patients accordingly.

Commercial insurance: Typically pays 100-150% of Medicare rates. Many states now have telehealth parity laws requiring insurers to pay the same for telehealth as in-person:

• California (AB 744): Required since 2021
• Illinois: Parity law enacted 2021
• New York: Telehealth parity for mental health
• Texas: No state mandate, but many insurers voluntarily pay equivalent rates

The Economics of Patient Acquisition (Reality Check)

Let’s talk about what it actually costs to build an anxiety treatment practice from scratch.

If you try to acquire patients on your own through traditional marketing:

SEO (Search Engine Optimization):

• Takes 6-12 months of consistent investment before meaningful patient flow
• Requires ongoing content creation, technical optimization, backlink building
• Monthly cost: $1,500-3,000+ for a quality agency or consultant
• Most solo providers don’t have the expertise or patience for this

Google Ads:

• Mental health keywords cost $15-40+ per click
• Most clicks don’t convert to booked patients
• Realistic cost per booked patient: $200-400+ after accounting for click costs, landing page optimization, staff time to handle leads, and no-show rates

Directory Listings (Psychology Today, Zocdoc):

• Monthly subscription fees: $30-100+ per directory
• Zocdoc charges per booking: $35-100+ per new patient
• You compete with hundreds of other providers on the same search results page
• Total monthly cost including subscriptions can easily hit $500-1,000+

The real all-in cost: When you factor in agency fees, ad spend, staff time to qualify leads, testing and optimization, failed campaigns, and no-show rates from cold leads, acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient — and that’s after months of investment with no guarantee of results.

Most providers starting out don’t have $3,000-5,000/month to gamble on marketing that might not work.

A Smarter Economic Model: Pay-Per-Appointment Platforms

This is where platforms like Klarity Health change the economics entirely.

Instead of spending thousands upfront with uncertain results, you pay a standard listing fee per new patient lead (similar to Zocdoc’s model). The key differences:

What you get:

• Pre-qualified patients already matched to your specialty and availability
• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule and only pay when you see patients

The value proposition: Instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient books with you. That’s guaranteed ROI vs gambling on marketing channels.

For established providers looking to scale: DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience. But for most psychiatrists and PMHNPs — especially those starting out or adding telehealth to their practice — a platform that handles patient acquisition removes the risk entirely and gets you seeing patients immediately.

What About Controlled Substances? The Details That Matter

Benzodiazepines are Schedule IV controlled substances. Here’s what you need to know:

DEA Registration Requirements

Both psychiatrists and PMHNPs must have a DEA registration to prescribe controlled substances. In most states, NPs can obtain a DEA registration independently (though some states require physician sign-off on the application).

PDMP Requirements (Mandatory in All States)

Before prescribing benzodiazepines or other controlled anxiolytics, you must check your state’s Prescription Drug Monitoring Program:

• Florida: E-FORCSE (mandatory check before prescribing)
• Texas: Texas PMP Aware (mandatory)
• New York: iSTOP (must check every time you prescribe a controlled substance — one of the strictest mandates)
• California, Pennsylvania, Illinois: All require PDMP checks before prescribing controlled substances

Clinical Guidelines (Not Just Legal Requirements)

The standard of care for prescribing benzodiazepines for anxiety has evolved:

First-line treatment for most anxiety disorders: SSRIs or SNRIs, not benzodiazepines. Reserve benzos for:

• Acute anxiety or panic attacks while waiting for SSRIs to take effect
• Short-term situational anxiety (specific phobia, procedure-related anxiety)
• Treatment-resistant cases where other options have failed

Documentation is crucial: When prescribing controlled substances via telehealth, document:

• Why benzodiazepines are clinically appropriate (vs alternatives)
• Informed consent discussion (addiction risk, tolerance, tapering plan)
• Patient’s substance use history
• PDMP check results
• Treatment agreement if long-term use is anticipated

This isn’t just about covering yourself legally — it’s about practicing good medicine and ensuring auditors or peer reviewers understand your clinical reasoning.

Building Your Telehealth Anxiety Practice: Practical Next Steps

Whether you’re adding telehealth to an existing practice or going fully remote, here’s what matters:

For Psychiatrists

Multi-state licensing: If you want to treat patients across state lines, consider:

• Interstate Medical Licensure Compact (IMLC): Expedited licensing in 40+ member states (Texas, Illinois, Pennsylvania are members; California and New York are not)
• Cost: Compact fee + individual state license fees (typically $500-800 per state)
• Timeline: Can get licensed in multiple states within weeks vs months

Telehealth platform vs solo practice:

• Platform (like Klarity): Patient acquisition handled, billing managed, infrastructure provided — you just see patients
• Solo: Complete autonomy, higher per-visit revenue potential, but you handle all marketing, billing, EHR, tech stack

Revenue potential: A psychiatrist doing 20-25 medication management visits per week via telehealth at Medicare rates (~$95-135 per visit) can generate $8,000-14,000/month in collections. With commercial insurance (higher rates) or cash-pay, that increases significantly.

For PMHNPs

Know your state’s requirements:

• FPA states (NY, AZ, OR, WA, etc.): Get licensed, get DEA, start practicing
• Restricted states: Line up physician collaboration before you start marketing yourself

Telehealth platforms can help with collaboration: Some platforms pair NPs with collaborating physicians who meet state requirements — solving the biggest headache of practicing in restricted states.

Consider starting in FPA states: If you’re building a multi-state telehealth practice, prioritize states where you can practice independently. You’ll have more autonomy and fewer administrative hoops.

Revenue expectations: At 85% of physician Medicare rates, expect slightly lower reimbursement, but NP salaries are typically lower than MD salaries — which platforms account for in compensation models. The volume opportunity (treating patients across multiple states via telehealth) often more than compensates.

FAQ

Can a psychiatric nurse practitioner prescribe Xanax?

Yes, in all 50 states — but the conditions vary. In Full Practice Authority states (like New York, Arizona), a PMHNP can prescribe benzodiazepines independently. In restricted states (like Texas, Florida, Pennsylvania), you need a physician collaborative agreement that specifically authorizes controlled substance prescribing.

Do I need an in-person visit before prescribing anxiety meds via telehealth?

As of 2026, no federal requirement for an initial in-person visit before prescribing controlled substances via telehealth (under extended COVID-era flexibilities through Dec 2026). Some states may have additional requirements — verify your state’s rules. The DEA is expected to finalize permanent regulations in late 2026.

What’s the difference between a psychiatrist and PMHNP for prescribing anxiety meds?

Psychiatrists (MD/DO) have unrestricted prescribing authority in all states and don’t need physician oversight. PMHNPs have equivalent prescribing ability in Full Practice Authority states, but need physician collaboration/supervision in roughly half of U.S. states. Training also differs: psychiatrists complete 8+ years of medical school + residency; PMHNPs typically complete 2-3 years of graduate nursing education.

Can I prescribe controlled substances across state lines via telehealth?

You can prescribe controlled substances to patients in any state where you hold a valid license and DEA registration in that state. You cannot prescribe across state lines just because it’s telehealth — you must be licensed in the state where the patient is physically located during the visit.

What if DEA rules change in 2026?

The DEA’s permanent telemedicine prescribing regulations are expected in late 2026. They’ll likely introduce a special telemedicine registration or require some additional safeguards, but the goal is to preserve remote access while preventing diversion and abuse. Stay updated through DEA announcements and your professional associations.

How does reimbursement for telehealth compare to in-person?

Medicare and most states with telehealth parity laws pay the same rate for telehealth as in-person psychiatric visits. Some Medicaid programs and smaller private insurers may pay slightly less, but the trend is toward payment parity for mental health services.

The Bottom Line: Telehealth Anxiety Treatment Is Here to Stay

The anxiety treatment landscape has fundamentally changed. Telehealth isn’t a temporary COVID workaround — it’s now standard practice, with federal flexibilities extended through 2026 and likely to become permanent with some modifications.

For psychiatrists: You have full authority to treat anxiety disorders via telehealth, including prescribing controlled substances when clinically appropriate. The main challenge is navigating multi-state licensing and ensuring you follow each state’s PDMP and documentation requirements.

For PMHNPs: Your authority depends on your state. In Full Practice states, you’re on equal footing with psychiatrists. In restricted states, you need physician collaboration — but telehealth platforms can help solve that problem.

The opportunity: There’s massive demand for anxiety treatment (provider shortages in most states, rising anxiety cases post-pandemic, and long wait times for appointments). Telehealth platforms like Klarity offer a lower-risk path to building a practice: no upfront marketing spend, pre-qualified patients, and pay-per-appointment economics that guarantee ROI.

The question isn’t whether you can treat anxiety via telehealth — you can. The question is whether you’re ready to meet that demand.

Ready to explore telehealth opportunities? Join Klarity Health’s provider network to start seeing anxiety patients remotely with built-in patient acquisition, billing support, and telehealth infrastructure.

Sources and References

The following sources were consulted to provide up-to-date information as of February 26, 2026:

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov). Official government source on federal telehealth prescribing policy. Published Jan 2, 2026. www.hhs.gov

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov). State law defining NP scope and telehealth rules in Florida. 2024 Statutes. www.flsenate.gov | www.flsenate.gov

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov). State regulatory guidance on NP independent practice categories. Updated 2024. rn.ca.gov

4. NPNY announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com). NY NP association announcement of law changes. Published Apr 9, 2022. npny.enpnetwork.com

5. Texas Medical Board FAQ – NP prescribing of Schedule II (tmb.state.tx.us). State board guidance on physician delegation limits. Current law from 2019, accessed 2026. www.tmb.state.tx.us

All regulatory details were cross-checked with official state code or board websites for accuracy as of February 2026.

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs